ProACT Adjustable Continence Therapy for Men

FDA Premarket Approval P130018 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval to update the sterilization dose auditing frequency from every three to 12 months

DeviceProACT Adjustable Continence Therapy for Men
Generic NameDevice, Incontinence, Mechanical/hydraulic
ApplicantUROMEDICA INC
Date Received2021-05-18
Decision Date2021-06-10
PMAP130018
SupplementS002
Product CodeEZY 
Advisory CommitteeGastroenterology/Urology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address UROMEDICA INC 1840 Berkshire Lane N plymouth, MN 55441

Supplemental Filings

Supplement NumberDateSupplement Type
P130018Original Filing
S002 2021-05-18 30-day Notice
S001 2015-12-21 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.